Human leukocyte immunoglobulin-like receptors in health and disease

被引:14
|
作者
Redondo-Garcia, Silvia [1 ]
Barritt, Christopher [1 ,2 ,3 ]
Papagregoriou, Charys [1 ,6 ]
Yeboah, Muchaala [1 ]
Frendeus, Bjorn [1 ,4 ]
Cragg, Mark S. [1 ,5 ]
Roghanian, Ali [1 ,5 ]
机构
[1] Univ Southampton, Sch Canc Sci, Antibody & Vaccine Grp, Ctr Canc Immunol,Fac Med,Southampton Gen Hosp, Southampton, England
[2] Glasgow Royal Infirm, Lister Dept Gen Surg, Glasgow, Scotland
[3] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Scotland
[4] BioInvent Int AB, Lund, Sweden
[5] Univ Southampton, Inst Life Sci, Southampton, England
[6] Ctr Study Haematol & Other Malignancies, Nicosia, Cyprus
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
LILR; immune tolerance; cancer; autoimmunity; infection; immunomodulation; immunotherapy; MHC CLASS-I; SOLUBLE HLA-G; T-SUPPRESSOR-CELLS; ANTIGEN-PRESENTING CELLS; TOLEROGENIC ENDOTHELIAL-CELLS; PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYELOID-LEUKEMIA; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE;
D O I
10.3389/fimmu.2023.1282874
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human leukocyte immunoglobulin (Ig)-like receptors (LILR) are a family of 11 innate immunomodulatory receptors, primarily expressed on lymphoid and myeloid cells. LILRs are either activating (LILRA) or inhibitory (LILRB) depending on their associated signalling domains (D). With the exception of the soluble LILRA3, LILRAs mediate immune activation, while LILRB1-5 primarily inhibit immune responses and mediate tolerance. Abnormal expression and function of LILRs is associated with a range of pathologies, including immune insufficiency (infection and malignancy) and overt immune responses (autoimmunity and alloresponses), suggesting LILRs may be excellent candidates for targeted immunotherapies. This review will discuss the biology and clinical relevance of this extensive family of immune receptors and will summarise the recent developments in targeting LILRs in disease settings, such as cancer, with an update on the clinical trials investigating the therapeutic targeting of these receptors.
引用
收藏
页数:29
相关论文
共 50 条
  • [11] Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility
    Bossi, G.
    Mannarino, S.
    Pietrogrande, M. C.
    Salice, P.
    Dellepiane, R. M.
    Cremaschi, A. L.
    Corana, G.
    Tozzo, A.
    Capittini, C.
    De Silvestri, A.
    Tinelli, C.
    Pasi, A.
    Martinetti, M.
    GENES AND IMMUNITY, 2015, 16 (07) : 481 - 487
  • [12] Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility
    G Bossi
    S Mannarino
    M C Pietrogrande
    P Salice
    R M Dellepiane
    A L Cremaschi
    G Corana
    A Tozzo
    C Capittini
    A De Silvestri
    C Tinelli
    A Pasi
    M Martinetti
    Genes & Immunity, 2015, 16 : 481 - 487
  • [13] Complex interactions: The immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors
    Norman, PJ
    Parham, P
    SEMINARS IN HEMATOLOGY, 2005, 42 (02) : 65 - 75
  • [14] The leukocyte immunoglobulin-like receptors (LIRs): a new family of immune regulators
    Fanger, NA
    Borges, L
    Cosman, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (02) : 231 - 236
  • [15] Expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium: correlations to disease activity
    Tedla, N.
    An, H.
    Borges, L.
    Vollmer-Conna, U.
    Bryant, K.
    Geczy, C.
    McNeil, H. Patrick
    TISSUE ANTIGENS, 2011, 77 (04): : 305 - 316
  • [16] Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies
    Zhang, Jilu
    Mai, Sunny
    Chen, Hui-Ming
    Kang, Kyeongah
    Li, Xian Chang
    Chen, Shu-Hsia
    Pan, Ping-Ying
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (02) : 351 - 360
  • [17] Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes
    Wawina-Bokalanga, Tony
    Vanmechelen, Bert
    Lhermitte, Valentine
    Marti-Carreras, Joan
    Vergote, Valentijn
    Koundouno, Fara Raymond
    Akoi-Bore, Joseph
    Thom, Ruth
    Tipton, Tom
    Steeds, Kimberley
    Moussa, Keita Balla
    Amento, Ablam
    Laenen, Lies
    Duraffour, Sophie
    Gabriel, Martin
    Ruibal, Paula
    Hall, Yper
    Kader-Kond, Mandy
    Gunther, Stephan
    Baele, Guy
    Munoz-Fontela, Cesar
    Van Weyenbergh, Johan
    Carroll, Miles W.
    Maes, Piet
    EMERGING INFECTIOUS DISEASES, 2021, 27 (01) : 76 - 84
  • [18] Killer immunoglobulin-like receptors
    Moretta, L
    Moretta, A
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) : 626 - 633
  • [19] Killer immunoglobulin-like receptors/human leukocyte antigen class -I, a crucial immune pathway in cancer
    Xu, Yi
    Wang, Lei
    Li, Wei
    Chen, Bin
    Liu, Yu
    Wang, Hao
    Zhao, Sha
    Ye, Lingyun
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [20] Immunoglobulin-like receptors in chickens: identification, functional characterization, and renaming to cluster homolog of immunoglobulin-like receptors
    Sparling, Brandi A.
    Ng, Theros T.
    Carlo-Allende, Anaid
    McCarthy, Fiona M.
    Taylor Jr, Robert L.
    Drechsler, Yvonne
    POULTRY SCIENCE, 2024, 103 (02)